🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07366567
Starting soon Not applicable

Effect of Foot Bath on Pain, Sleep, and Comfort Levels After Abdominal Surgery

NCT07366567 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-12-29
Last updated
2026-01-26

Condition(s) studied

Pain, PostoperativeSleep

Investigational drug(s) / intervention(s)

Foot bath device

Foot bath device: On the day of surgery, patients will receive a foot bath between 9:00 PM and 10:00 PM. Any socks or clothing on both feet will be removed. The feet will be visually and manually examined to determine if they show any signs of illness (pressure ulcers, discoloration, wounds, etc.). The patient will be informed that the foot bath device is disinfected before each use and that water-tight bags will be placed around the device to prevent contact between the foot and the water to facilitate repeated use. The water temperature will be adjusted to 41-42°C using an infrared thermometer (non-contact digital thermometer). Both feet will be placed inside the foot bath device. The patient's feet will remain in the foot bath device for 20 minutes. After the foot bath, the patient's feet will be thoroughly dried with a towel, and the patient will be re-dressed in their existing socks or anti-embolic stockings. Any side effects/adverse reactions, etc., related to the foot bath will be questioned and

Study summary

The aim of this study was to investigate the effects of foot bath application on pain level, comfort and sleep quality in the postoperative period.

H1: Foot baths have a postoperative pain-reducing effect. H2: Foot baths have a postoperative comfort-enhancing effect. H3: Foot baths have a postoperative sleep-improving effect.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * who are hospitalized in the General Surgery Clinic, * are on day 0 of surgery, * volunteer to participate in the study, * have no neuropsychiatric diagnosis and are not taking antipsychotic medications, * are over 18 years of age, * accept random selection, * and undergo abdominal surgery. * For the experimental group, all patients with no infectious diseases (shingles, fungal infections, eczema, warts, calluses), local infections (abscesses, etc.), open lesions/wounds, scar tissue, edema, hematomas, thrombophlebitis, deep vein thrombosis, lymphangitis, coagulation disorders, varicose veins, osteoporosis, osteomyelitis, hepatitis, degenerative joint diseases, neuropathy due to diabetes, toe deformities, recent fractures, dislocations, or ruptures of muscle fibers, tendons, or ligaments will be included in the sample. Exclusion Criteria: * patients who underwent multiple simultaneous surgeries along with abdominal surgery, * those with postoperative complications such as delirium, * those who underwent reoperation, * those with a pain score \>7 because it could affect sleep levels, * and those who received narcotic analgesics on postoperative day 0 due to pain will be excluded from the sample.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Trakya University Hospital Edirne Cahit Arf Boulevard

More Trakya University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07366567 on ClinicalTrials.gov ↗ ← All trials in Turkey